Invivyd (IVVD) Other Operating Expenses (2021 - 2025)
Invivyd posted quarterly Other Operating Expenses of $1.1 million for Q4 2025, up 57.46% year-on-year from $724000.0 in Q4 2024, and up 4.78% on a QoQ basis from $1.1 million in Q3 2025.
Invivyd (IVVD) has 5 years of Other Operating Expenses data on file, last reported at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses rose 57.46% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.7 million (up 131.58% YoY), and the FY2025 full-year result was $3.7 million, up 131.58% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $1.1 million, up from $1.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $17.8 million in Q4 2022 and bottomed at -$600000.0 in Q4 2023.
- The 5-year median for Other Operating Expenses is $917000.0 (2021), against an average of $2.5 million.
- The widest annual swing landed in 2023, when Other Operating Expenses sank 103.38%; it then surged 678.41% in 2025.
- A 5-year view of Other Operating Expenses shows it stood at $4.0 million in 2021, then soared by 344.32% to $17.8 million in 2022, then tumbled by 103.38% to -$600000.0 in 2023, then soared by 220.67% to $724000.0 in 2024, then surged by 57.46% to $1.1 million in 2025.
- The last three Other Operating Expenses figures came in at $1.1 million (Q4 2025), $1.1 million (Q3 2025), and $685000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 685,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 724,000.00 |
| Sep 30, 2024 | 806,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Dec 31, 2023 | -600,000.00 |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 825,000.00 |
| Dec 31, 2022 | 17.77 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 1.00 Mn |